Johnson & Johnson is paying $3.05 billion to acquire Halda Therapeutics, obtaining a novel cell death platform while ...

New hope for advanced prostate cancer patients, with promising new drug combo that targets genes, such as BRCA1, BRCA2, CHEK2 ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Scientists have uncovered a critical weakness in prostate cancer’s defences. The disease relies on two enzymes, PDIA1 and ...

Johnson & Johnson said on Monday it would buy privately held Halda Therapeutics for $3.05 billion in cash, expanding its ...

Scientists have discovered a critical weakness in prostate cancer cells involving two enzymes, PDIA1 and PDIA5, that protect ...

Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small-cap biotech stocks to buy according to analysts. On November ...

Prostate and skin cancers are among the most common cancers affecting men. In Advanced Prostate Cancer, lifelong treatment ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Grey’s Anatomy star James Pickens Jr. has revealed his recent prostate cancer diagnosis, urging men to pay attention to early ...